Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Renalytix ( (GB:RENX) ).
Renalytix PLC has announced a significant change in its shareholder structure, with UBS Group AG’s trading book holdings in the company falling below the 5% threshold. This change means that UBS’s holdings in Renalytix are now exempt from reporting obligations, indicating a potential shift in the investment landscape for the company.
More about Renalytix
Average Trading Volume: 1,400
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $43.29M
For an in-depth examination of RENX stock, go to TipRanks’ Stock Analysis page.